Literature DB >> 7164143

Pulmonary paragonimiasis in Cameroon.

P N Kum, T C Nchinda.   

Abstract

Paragonimus africanus has been known to be endemic in the Bakossi area of Meme Division of Cameroon since it was first described in 1952. After a lapse of 25 years, exploratory work was undertaken in the area (but not in the same villages) to study the prevalence of the disease, to record the common presenting symptoms, to make a number of paraclinical examinations, to assess the beliefs and attitudes of the people towards the disease and the possible reasons for its persistent endemicity in that area and to carry out a therapeutic trial with Niclofolan (Bilevon). The disease was found to have a prevalence of 5% with a higher prevalence among those less than 20 years old. Boys were more affected than girls. The population did not appear to recognize the disease which they confused with tuberculosis. The disease was contracted by eating improperly cooked crabs, the intermediate host. The therapeutic trial with Bilevon given orally as a single dose was completely successful. This study showed that paragonimiasis must be considered seriously in the differential diagnosis of tuberculosis in this area and that a study on a much wider scale is required to establish the real extent of the disease.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7164143     DOI: 10.1016/0035-9203(82)90102-x

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  2 in total

1.  Endemicity of Paragonimus and paragonimiasis in Sub-Saharan Africa: A systematic review and mapping reveals stability of transmission in endemic foci for a multi-host parasite system.

Authors:  Muriel Rabone; Joris Wiethase; Paul F Clark; David Rollinson; Neil Cumberlidge; Aidan M Emery
Journal:  PLoS Negl Trop Dis       Date:  2021-02-05

2.  An epidemiological study of pleuropulmonary paragonimiasis among pupils in the peri-urban zone of Kumba town, Meme Division, Cameroon.

Authors:  Roger Moyou-Somo; Charles Kefie-Arrey; Georges Dreyfuss; Michel Dumas
Journal:  BMC Public Health       Date:  2003-12-16       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.